OssiFi takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation. We are looking to expand our team, do you demonstrate the talent we are seeking?
Contact Us
Thank you for contacting us. We will get back to you as soon as possible.
Oops, there was an error sending your message. Please try again later.
Corporate Development
Privately held company. Since its inception, it has been capitalized using convertible notes, non-dilutive grants, and equity.
OssiFi is developing best in class sclerostin small molecule inhibitors to take advantage of new opportunities to develop safer, more effective bone building therapies.
OssiFi Therapeutics is an innovative bone-biology company operating at the intersection of therapeutics and medical devices to address significant unmet needs in neurogenic low back pain, fracture repair, and fracture prevention.